共 491 条
[1]
Abiko K(2013)PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction Clin Cancer Res 19 1363-1374
[2]
Mandai M(2008)Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival Gynecol Oncol 109 174-181
[3]
Hamanishi J(2009)Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 Nature 462 108-112
[4]
Yoshioka Y(2010)Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype Gynecol Oncol 116 556-562
[5]
Matsumura N(2012)The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Nature 483 603-607
[6]
Baba T(2004)PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells Cancer Res 64 1140-1145
[7]
Yamaguchi K(2013)Latest research and treatment of advanced-stage epithelial ovarian cancer Nat Rev Clin Oncol 10 211-224
[8]
Murakami R(2004)Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 942-949
[9]
Yamamoto A(2007)Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer Clin Cancer Res 13 4139-4145
[10]
Kharma B(2002)Cancer immunoediting: from immunosurveillance to tumor escape Nat Immunol 3 991-998